Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc)

NCT00684255 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped inactive

Conditions

Systemic Lupus Erythematosus
Systemic Sclerosis

Interventions

PROCEDURE: Reduced Intensity Allogeneic Transplant
DRUG: Fludarabine
DRUG: Busulfan
DRUG: Campath

Sponsor

New York Medical College